What Catalysts Are Quietly Shifting The Narrative For Insmed (INSM)? [Yahoo! Finance]
Insmed, Inc. (INSM)
Last insmed, inc. earnings: 4/30 07:30 am
Check Earnings Report
US:NASDAQ Investor Relations:
investor.insmed.com
Company Research
Source: Yahoo! Finance
rate from 7.04% to about 7.07% and essentially unchanged revenue growth assumptions around 91.08%. That tiny move in the price target reflects bullish commentary around Brinsupri's EC approval, recent Q3 execution, and the broader respiratory pipeline, while still factoring in cautions about funding needs and market access. Stay with this article to see how you can keep on top of these kinds of narrative tweaks as they develop. Stay updated as the Fair Value for Insmed shifts by adding it to your watchlist or portfolio . Alternatively, explore our Community to discover new perspectives on Insmed. ?? Bullish Takeaways Recent research is largely constructive on Insmed, with UBS, TD Cowen, Truist, BofA and Cantor Fitzgerald all using positive ratings while refining their price targets around the updated Brinsupri outlook, Q3 execution and the broader respiratory portfolio. TD Cowen highlights formal EC approval for Brinsupri in NCFBE with 2+ exacerbations and points to expected a
Show less
Read more
Impact Snapshot
Event Time:
INSM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
INSM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
INSM alerts
High impacting Insmed, Inc. news events
Weekly update
A roundup of the hottest topics
INSM
News
- INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Insmed Incorporated - INSMPR Newswire
- INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Insmed Incorporated - INSMGlobeNewswire
- Insmed CEO Will Lewis talks its rare disease drug pipeline [CNBC]CNBC
- Insmed (NASDAQ:INSM) was given a new $205.00 price target on by analysts at Truist Financial Corporation.MarketBeat
- Is It Too Late To Reassess Insmed (INSM) After Its Huge Share Price Surge? [Yahoo! Finance]Yahoo! Finance
INSM
Earnings
- 10/30/25 - Miss
INSM
Sec Filings
- 1/13/26 - Form 4
- 1/13/26 - Form 4
- 1/12/26 - Form 144
- INSM's page on the SEC website